Altre lingue Syncona Limited

Azioni

Mercato chiuso - London S.E. Altri mercati azionari 17:35:14 26/04/2024			Variaz. 5gg	Var. 1 gen.
128,4 ^GBX	+1,10%		+5,77%	+4,05%

11/04	Syncona si accorda per la vendita di una partecipazione in una società partecipata per 7,4 milioni di sterline	AN
11/04	Syncona venderà una partecipazione nella società di portafoglio a Century Therapeutics	MT

Syncona agrees to sell stake in investee company for GBP7.4 million	11/04
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	11/04
Syncona : Ascend acquires GMP manufacturing capacity in Alachua, Florida; Enters long-term partnership with Beacon Therapeutics for clinical and commercial AAV production	09/04
BEST OF THE BROKERS	08/04
Syncona notes investee Achilles's annual loss narrows	04/04
Syncona : Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA)	02/04
Syncona : Autolus Therapeutics Announces Changes to its Board of Directors (1)	02/04
Syncona portfolio company Autolus posts widened loss for 2023	14/03
Syncona’s Takeover of Freeline Therapeutics Becomes Effective	20/02
Freeline shareholders approve Syncona acquisition	12/02
Freeline Therapeutics' Shareholders Approve Acquisition by Syncona	12/02
Syncona portfolio strengthens in third quarter thanks to Autolus	08/02
Syncona's Fiscal Q3 NAV Declines	08/02
Tranche Update on Syncona Limited's Equity Buyback Plan announced on September 29, 2023.	08/02
Syncona notes FDA acceptance of Autolus's BLA for obe-cel	22/01
Syncona says Freeline trial for Gaucher disease treatment positive	19/01
Syncona : Anaveon announces publication of ANV419 Phase I data in The Journal for ImmunoTherapy of Cancer	14/12
Pharma und Gesundheit: weitere Konsolidierung	13/12
Farma en gezondheid: consolidatie gaat door	12/12
Farmacia y salud: La consolidación continúa	11/12

Non ci sono risultati per questa ricerca